Trionid
Rx182 mcg+10.4 mcg+5.5 mcg • Metered-Dose Inhaler (MDI)
Indications & Uses
Trionid is indicated for:
Dosage Reference
Reference Information Only
Dosages shown are general references from official sources. Always consult your doctor or pharmacist for personalized dosing.
Adults:
Route of Administration: For oral inhalation only.Recommended doses: 2 inhalations twice daily in the morning and the evening. The maximum dose is two inhalations twice daily. After inhalation, the patient should rinse the mouth with water without swallowing.
Side Effects
The most common side effects include upper respiratory tract infection, pneumonia, back pain, oral candidiasis, influenza, muscle spasms, urinary tract infection, cough, sinusitis, and diarrhea.
Cautions & Contraindications
Warnings & Precautions
This inhaler is not indicated to be used for the relief of acute symptoms (as rescue therapy for the treatment of acute episodes of bronchospasm). The daily dosage should not be increased beyond the recommended dose. Patients should not use another medicine containing a LABA (Salmeterol, Formoterol Fumarate, Arformoterol Tartrate, or Indacaterol) for any reason. Caution should be exercised when considering the co-administration with long-term Ketoconazole, and other known strong CYP3A4 inhibitors (Ritonavir, Atazanavir, Clarithromycin, Indinavir, Itraconazole, Nefazodone, Nelvfinavir, Saquinavir, Telithromycin). Since patients with COPD often have multiple risk factors for reduced BMD, assessment of BMD is recommended before initiating Trionid and periodically thereafter.
Contraindications
It is contraindicated in patients who have demonstrated hypersensitivity to Budesonide, Formoterol Fumarate, Glycopyrronium, or any of the excipients.